Pediatric brain tumors: A neuropathologist's approach to the integrated diagnosis.

brain central nervous system glioma integrated diagnosis molecular pediatric tumor

Journal

Frontiers in pediatrics
ISSN: 2296-2360
Titre abrégé: Front Pediatr
Pays: Switzerland
ID NLM: 101615492

Informations de publication

Date de publication:
2023
Historique:
received: 12 01 2023
accepted: 14 02 2023
entrez: 27 3 2023
pubmed: 28 3 2023
medline: 28 3 2023
Statut: epublish

Résumé

The classification of tumors of the central nervous system (CNS) is a rapidly evolving field. While tumors were historically classified on the basis of morphology, the recent integration of molecular information has greatly refined this process. In some instances, molecular alterations provide significant prognostic implications beyond what can be ascertained by morphologic examination alone. Additionally, tumors may harbor molecular alterations that provide a therapeutic target. Pediatric CNS tumors, in particular, rely heavily on the integration of molecular data with histologic, clinical, and radiographic features to reach the most accurate diagnosis. This review aims to provide insight into a neuropathologist's approach to the clinical workup of pediatric brain tumors with an ultimate goal of reaching an integrated diagnosis that provides the most accurate classification and informs prognosis and therapy selection. The primary focus will center on how histology and molecular findings are used in combination with clinical and radiographic information to reach a final, integrated diagnosis.

Identifiants

pubmed: 36969278
doi: 10.3389/fped.2023.1143363
pmc: PMC10030595
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

1143363

Informations de copyright

© 2023 Viaene.

Déclaration de conflit d'intérêts

The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Neuropathol Appl Neurobiol. 2020 Aug;46(5):422-430
pubmed: 31867747
Oncotarget. 2018 Dec 14;9(98):37112-37124
pubmed: 30647848
Brain Pathol. 2014 Sep;24(5):429-35
pubmed: 24990071
Acta Neuropathol. 2013 Jun;125(6):913-6
pubmed: 23670100
Lab Invest. 2022 Feb;102(2):160-171
pubmed: 34848827
Nature. 2016 Nov 10;539(7628):309-313
pubmed: 27806376
Pediatr Dev Pathol. 2022 Jan-Feb;25(1):34-45
pubmed: 35168419
Acta Neuropathol. 2014 Oct;128(4):573-81
pubmed: 25047029
J Neurosci. 2014 Oct 29;34(44):14644-51
pubmed: 25355217
Am J Surg Pathol. 2021 Feb 1;45(2):200-204
pubmed: 33428336
Neuro Oncol. 2019 Aug 5;21(8):968-980
pubmed: 30805642
Acta Neuropathol. 2013 Mar;125(3):359-71
pubmed: 23291781
Brain Pathol. 2013 Sep;23(5):558-64
pubmed: 23414300
Science. 2017 Mar 31;355(6332):
pubmed: 28360267
Pediatr Dev Pathol. 2022 Jan-Feb;25(1):46-58
pubmed: 33872106
Neuro Oncol. 2021 Jan 30;23(1):34-43
pubmed: 33130881
Acta Neuropathol. 2018 Aug;136(2):273-291
pubmed: 29564591
Acta Neuropathol. 2018 Mar;135(3):481-484
pubmed: 29372318
Nature. 2014 Feb 27;506(7489):445-50
pubmed: 24553142
Acta Neuropathol. 2009 Nov;118(5):599-601
pubmed: 19798509
Cancer Cell. 2017 Oct 9;32(4):520-537.e5
pubmed: 28966033
Pediatr Dev Pathol. 2022 Jan-Feb;25(1):59-67
pubmed: 35168420
Am J Surg Pathol. 2004 May;28(5):644-50
pubmed: 15105654
Am J Surg Pathol. 2011 Jun;35(6):933-5
pubmed: 21566516
Neuro Oncol. 2022 Apr 1;24(4):571-581
pubmed: 34555175
Brain Behav. 2017 Feb 10;7(3):e00641
pubmed: 28293477
Cancer Cell. 2015 May 11;27(5):728-43
pubmed: 25965575
Pediatr Dev Pathol. 2022 Jan-Feb;25(1):23-33
pubmed: 35168417
Neurooncol Adv. 2022 Aug 19;4(1):vdac133
pubmed: 36105387
Nature. 2018 Mar 22;555(7697):469-474
pubmed: 29539639
Acta Neuropathol. 2011 Mar;121(3):381-96
pubmed: 21267586
Childs Nerv Syst. 2016 Oct;32(10):1833-8
pubmed: 27659826
Acta Neuropathol. 2017 Nov;134(5):705-714
pubmed: 28733933
Cell. 2011 Jul 22;146(2):209-21
pubmed: 21737130
Acta Neuropathol. 2018 Feb;135(2):299-301
pubmed: 29302777
Arch Pathol Lab Med. 2020 Feb;144(2):196-206
pubmed: 31219344
Acta Neuropathol Commun. 2020 Nov 5;8(1):183
pubmed: 33153494
Acta Neuropathol. 2018 Apr;135(4):639-642
pubmed: 29497819
Acta Neuropathol. 2014 Nov;128(5):743-53
pubmed: 25200322
Cancer Res. 2001 Jul 1;61(13):4956-60
pubmed: 11431323
Nat Commun. 2019 Sep 25;10(1):4343
pubmed: 31554817
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931
Cancer Cell. 2016 Mar 14;29(3):379-393
pubmed: 26923874
Acta Neuropathol Commun. 2020 Mar 12;8(1):30
pubmed: 32164789
Acta Neuropathol. 2015 Jan;129(1):133-46
pubmed: 25427834
Acta Neuropathol. 2019 Aug;138(2):309-326
pubmed: 31076851
Cancer Cell. 2016 Dec 12;30(6):891-908
pubmed: 27960086

Auteurs

Angela N Viaene (AN)

Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, United States.
Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, United States.

Classifications MeSH